Literature DB >> 22454789

Neurophysiology of Nicotine Addiction.

John A Dani1, Daniel Jenson, John I Broussard, Mariella De Biasi.   

Abstract

Tobacco use is a major health problem, and nicotine is the main addictive component. Nicotine binds to nicotinic acetylcholine receptors (nAChR) to produce its initial effects. The nAChRs subtypes are composed of five subunits that can form in numerous combinations with varied functional and pharmacological characteristics. Diverse psychopharmacological effects contribute to the overall process of nicotine addiction, but two general neural systems are emerging as critical for the initiation and maintenance of tobacco use. Mesocorticolimbic circuitry that includes the dopaminergic pathway originating in the ventral tegmental area and projecting to the nucleus accumbens is recognized as vital for reinforcing behaviors during the initiation of nicotine addiction. In this neural system β2, α4, and α6 are the most important nAChR subunits underlying the rewarding aspects of nicotine and nicotine self-administration. On the other hand, the epithalamic habenular complex and the interpeduncular nucleus, which are connected via the fasciculus retroflexus, are critical contributors regulating nicotine dosing and withdrawal symptoms. In this case, the α5 and β4 nAChR subunits have critical roles in combination with other subunits. In both of these neural systems, particular nAChR subtypes have roles that contribute to the overall nicotine addiction process.

Entities:  

Year:  2011        PMID: 22454789      PMCID: PMC3312002          DOI: 10.4172/2155-6105.S1-001

Source DB:  PubMed          Journal:  J Addict Res Ther


  127 in total

1.  Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas.

Authors:  J A Dani; K A Radcliffe; V I Pidoplichko
Journal:  Eur J Pharmacol       Date:  2000-03-30       Impact factor: 4.432

Review 2.  Molecular and cellular aspects of nicotine abuse.

Authors:  J A Dani; S Heinemann
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

Review 3.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

4.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

5.  Bupropion hydrochloride produces conditioned hyperactivity in rats.

Authors:  Jamie L Wilkinson; Rick A Bevins
Journal:  Physiol Behav       Date:  2007-01-18

Review 6.  Nicotine and endogenous opioids: neurochemical and pharmacological evidence.

Authors:  Maria Hadjiconstantinou; Norton H Neff
Journal:  Neuropharmacology       Date:  2010-11-22       Impact factor: 5.250

7.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice.

Authors:  Ramiro Salas; Renea Sturm; Jim Boulter; Mariella De Biasi
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

9.  Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.

Authors:  Sharon R Grady; Milena Moretti; Michele Zoli; Michael J Marks; Alessio Zanardi; Luca Pucci; Francesco Clementi; Cecilia Gotti
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

10.  Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine.

Authors:  Tianxiang Zhang; Lifen Zhang; Yong Liang; Athanassios G Siapas; Fu-Ming Zhou; John A Dani
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

View more
  19 in total

Review 1.  Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.

Authors:  Asti Jackson; Ben Grobman; Suchitra Krishnan-Sarin
Journal:  Neuropharmacology       Date:  2020-06-24       Impact factor: 5.250

2.  Cholinergic transmission during nicotine withdrawal is influenced by age and pre-exposure to nicotine: implications for teenage smoking.

Authors:  Luis M Carcoba; James E Orfila; Luis A Natividad; Oscar V Torres; Joseph A Pipkin; Patrick L Ferree; Eddie Castañeda; Donald E Moss; Laura E O'Dell
Journal:  Dev Neurosci       Date:  2014-05-15       Impact factor: 2.984

3.  Sex differences in cholinergic systems in the interpeduncular nucleus following nicotine exposure and withdrawal.

Authors:  Victor L Correa; Rodolfo J Flores; Luis M Carcoba; Montserrat C Arreguin; Laura E O'Dell
Journal:  Neuropharmacology       Date:  2019-07-17       Impact factor: 5.250

4.  Finding genomic function for genetic associations in nicotine addiction research: the ENCODE project's role in future pharmacogenomic analysis.

Authors:  David J Vandenbergh; Gabriel L Schlomer
Journal:  Pharmacol Biochem Behav       Date:  2014-01-31       Impact factor: 3.533

Review 5.  HIV, Tat and dopamine transmission.

Authors:  Peter J Gaskill; Douglas R Miller; Joyonna Gamble-George; Hideaki Yano; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2017-04-27       Impact factor: 5.996

6.  Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.

Authors:  Andrew C Meyer; Nichole M Neugebauer; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  J Neurochem       Date:  2013-08-20       Impact factor: 5.372

Review 7.  Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems.

Authors:  Kristen M Mackowick; Mera S Barr; Victoria C Wing; Rachel A Rabin; Clairelaine Ouellet-Plamondon; Tony P George
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-07-19       Impact factor: 5.067

Review 8.  Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.

Authors:  Wei-Lun Sun; Pamela M Quizon; Jun Zhu
Journal:  Prog Mol Biol Transl Sci       Date:  2015-11-17       Impact factor: 3.622

9.  Intravenous nicotine injection induces rapid, experience-dependent sensitization of glutamate release in the ventral tegmental area and nucleus accumbens.

Authors:  Magalie Lenoir; Eugene A Kiyatkin
Journal:  J Neurochem       Date:  2013-10-21       Impact factor: 5.372

10.  Menthol facilitates dopamine-releasing effect of nicotine in rat nucleus accumbens.

Authors:  Meiyu Zhang; Erin Harrison; Lisa Biswas; Thuy Tran; Xiu Liu
Journal:  Pharmacol Biochem Behav       Date:  2018-09-08       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.